CATABASIS PHARMACEUTICALS IN's ticker is CATB and the CUSIP is 14875P107. A total of 30 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $232,000 | -16.5% | 290,471 | 0.0% | 0.00% | – |
| Q2 2018 | $278,000 | +101.4% | 290,471 | +279.1% | 0.00% | – |
| Q1 2018 | $138,000 | +21.1% | 76,612 | 0.0% | 0.00% | – |
| Q4 2017 | $114,000 | +72.7% | 76,612 | +146.1% | 0.00% | – |
| Q3 2017 | $66,000 | +50.0% | 31,136 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | -17.0% | 31,136 | -7.2% | 0.00% | – |
| Q1 2017 | $53,000 | -55.5% | 33,535 | +1.0% | 0.00% | – |
| Q4 2016 | $119,000 | -41.4% | 33,211 | +0.7% | 0.00% | – |
| Q3 2016 | $203,000 | +67.8% | 32,995 | +0.2% | 0.00% | – |
| Q2 2016 | $121,000 | -35.3% | 32,941 | -11.3% | 0.00% | – |
| Q1 2016 | $187,000 | -36.6% | 37,153 | -0.1% | 0.00% | – |
| Q4 2015 | $295,000 | +12.2% | 37,207 | +14.3% | 0.00% | – |
| Q3 2015 | $263,000 | – | 32,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,857,667 | $4,572,000 | 5.05% |
| Clarus Ventures, LLC | 2,752,488 | $4,404,000 | 3.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 388,030 | $621,000 | 0.12% |
| Rhenman & Partners Asset Management AB | 310,756 | $497,000 | 0.08% |
| BOSTON FAMILY OFFICE LLC | 24,467 | $39,000 | 0.01% |
| OPPENHEIMER & CO INC | 90,000 | $144,000 | 0.00% |
| Alyeska Investment Group, L.P. | 221,281 | $354,000 | 0.00% |
| A.R.T. Advisors, LLC | 46,747 | $74,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 101,347 | $162,000 | 0.00% |
| Acrospire Investment Management LLC | 680 | $1,000 | 0.00% |